Showing results (11-20 of 45) with videos related to
Sort By:
Pageof 5
Molecular Biology of the Cell|June 3, 2005
EHD proteins associate with syndapin I and II and such interactions play a crucial role in endosomal recyclingAnne Braun, Roser Pinyol, Regina Dahlhaus, et al.Nature Cancer|April 28, 2022
Molecular pathogenesis and systemic therapies for hepatocellular carcinomaJosep M Llovet, Roser Pinyol, Robin K Kelley, et al.Nature Reviews. Clinical Oncology|February 29, 2024
Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinomaJosep M Llovet, Roser Pinyol, Mark Yarchoan, et al.Cell|April 17, 2026
Hallmarks of liver cancer: Therapeutic implicationsJosep M Llovet, Roser Pinyol, Silvia Affo, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|February 8, 2021
Liver Injury Increases the Incidence of HCC following AAV Gene Therapy in MiceDhwanil A Dalwadi, Laura Torrens, Jordi Abril-Fornaguera, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2022
Cabozantinib Enhances Anti-PD1 Activity and Elicits a Neutrophil-Based Immune Response in Hepatocellular CarcinomaRoger Esteban-Fabró, Catherine E Willoughby, Marta Piqué-Gili, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2020
Copy-Number Alteration Burden Differentially Impacts Immune Profiles and Molecular Features of Hepatocellular CarcinomaLaia Bassaganyas, Roser Pinyol, Roger Esteban-Fabró, et al.British Journal of Cancer|July 10, 2019
Molecular portrait of high alpha-fetoprotein in hepatocellular carcinoma: implications for biomarker-driven clinical trialsRobert Montal, Carmen Andreu-Oller, Laia Bassaganyas, et al.Gastroenterology|July 26, 2019
An Immune Gene Expression Signature Associated With Development of Human Hepatocellular Carcinoma Identifies Mice That Respond to Chemopreventive AgentsAgrin Moeini, Sara Torrecilla, Victoria Tovar, et al.Gastroenterology|September 11, 2016
IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental ModelsIris Martinez-Quetglas, Roser Pinyol, Daniel Dauch, et al.Pageof 5